Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.creatorMitxelena-Iribarren, O. (Oihane)-
dc.creatorLizarbe-Sancha, S. (Sara)-
dc.creatorCampisi, J. (Jay)-
dc.creatorArana-Alonso, S. (Sergio)-
dc.creatorMujika-Garmendia, M. (Maite)-
dc.date.accessioned2023-12-04T12:47:11Z-
dc.date.available2023-12-04T12:47:11Z-
dc.date.issued2021-06-04-
dc.identifier.citationMitxelena-Iribarren, O., Lizarbe-Sancha, S., Campisi, J., Arana, S., & Mujika, M. (2021). Different Microfluidic Environments for In Vitro Testing of Lipid Nanoparticles against Osteosarcoma. Bioengineering, 8(6), 77.es_ES
dc.identifier.issn2306-5354-
dc.identifier.urihttps://hdl.handle.net/10171/67991-
dc.description.abstractThe use of lipid nanoparticles as biodegradable shells for controlled drug delivery shows promise as a more effective and targeted tumor treatment than traditional treatment methods. Although the combination of target therapy with nanotechnology created new hope for cancer treatment, methodological issues during in vitro validation of nanovehicles slowed their application. In the current work, the effect of methotrexate (MTX) encapsulated in different matrices was evaluated in a dynamic microfluidic platform. Effects on the viability of osteosarcoma cells in the presence of recirculation of cell media, free MTX and two types of blank and drug-containing nanoparticles were successfully assessed in different tumor-mimicking microenvironments. Encapsulated MTX was more effective than the equal dose free drug treatment, as cell death significantly increased under the recirculation of both types of drug-loaded nanoparticles in all concentrations. In fact, MTX-nanoparticles reduced cell population 50 times more than the free drug when 150-mu M drug dose was recirculated. Moreover, when compared to the equivalent free drug dose recirculation, cell number was reduced 60 and 100 points more under recirculation of each nanoparticle with a 15-mu M drug concentration. Thus, the results obtained with the microfluidic model present MTX-lipid nanoparticles as a promising and more effective therapy for pediatric osteosarcoma treatment than current treatment options.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectLipid nanoparticlees_ES
dc.subjectMethotrexatees_ES
dc.subjectEncapsulation matrixes_ES
dc.subjectTumor-on-a-chipes_ES
dc.titleDifferent microfluidic environments for In vitro testing of lipid nanoparticles against osteosarcomaes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.editorial.noteThis article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.es_ES
dc.identifier.doi10.3390/bioengineering8060077-
dc.identifier.pmid34199965-

Ficheros en este ítem:
Vista previa
Fichero
bioengineering-08-00077.pdf
Descripción
Tamaño
2.61 MB
Formato
Adobe PDF


Estadísticas e impacto
0 citas en
0 citas en

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.